Dunhill Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18 Sell
3
-2
-40% -$9 ﹤0.01% 1807
2026
Q2
$28 Hold
5
– – ﹤0.01% 1572
2026
Q1
$11 Hold
5
– – ﹤0.01% 1818
2025
Q4
$21 Buy
+5
New +$28 ﹤0.01% 1897

Other funds holding EVH

Dunhill Financial's EVH Position: Q3 2026 in Review

Dunhill Financial reduced its Evolent Health (EVH) stake by 40% in Q3 2026, selling an estimated $9 and leaving 3 shares worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Dunhill Financial first reported a position in EVH in Q4 2025 and has held it in 4 quarters since. The position peaked at $28 in Q2 2026. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Dunhill Financial held 3 shares of Evolent Health worth $18 as of Q3 2026.
  • Dunhill Financial sold 2 Evolent Health shares in Q3 2026, an estimated $9.
  • Evolent Health made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1807 holding.
  • Dunhill Financial first reported a position in Evolent Health in Q4 2025 and has held it in 4 quarters since.
  • Dunhill Financial's Evolent Health position peaked at $28 in Q2 2026.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.